OCEA(Delisted)
Ocean Biomedical·NASDAQ
--
--(--)
OCEA fundamentals
During Q4 2024, Ocean Biomedical (OCEA) reported revenue of --, a YoY change of 0.00%. Net income was 283.00K, a YoY change of 101.68%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | TTM |
|---|
Start Date | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | -- |
End Date | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 42.72K -- | 523.76K -- | 5.11M -- | 6.90M -- | 3.17M +7327.78% | 938.00K +79.09% | 5.39M +5.42% | 2.83M -58.96% | 2.65M -16.33% | -660.00K -170.36% | 595.00K -88.95% | 682.00K -75.92% | -- -- | -- -- | -- -- |
Selling, General and Administrative Expenses | -- -- | -- -- | 1.91M -- | 3.71M -- | 1.31M -- | 777.00K -- | 4.99M +161.19% | 2.80M -24.38% | 2.35M +78.71% | -643.00K -182.75% | 569.00K -88.61% | 682.00K -75.68% | -- -- | -- -- | -- -- |
Research and Development Expenses | -- -- | -- -- | 3.20M -- | 3.19M -- | 1.86M -- | 161.00K -- | 393.00K -87.71% | 28.00K -99.12% | 305.00K -83.58% | -17.00K -110.56% | 26.00K -93.38% | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | 42.72K -- | 523.76K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -42.72K -- | -523.76K -- | -5.11M -- | -6.90M -- | -3.17M -7327.78% | -938.00K -79.09% | -5.39M -5.42% | -2.83M +58.96% | -2.65M +16.33% | 660.00K +170.36% | -595.00K +88.95% | -682.00K +75.92% | -- -- | -- -- | -- -- |
Non-Operating Income (Loss) | 173 -- | 2.27K -- | -265.00K -- | -433.00K -- | -495.00K -286227.17% | -45.00K -2078.02% | -66.70M -25071.70% | -8.60M -1885.91% | -11.43M -2209.49% | -17.52M -38824.44% | 13.59M +120.38% | -16.55M -92.49% | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -249.00K -- | -384.00K -- | -434.00K -- | 1.07M -- | -66.40M -26568.27% | -7.93M -1965.36% | -11.14M -2466.59% | -17.02M -1687.31% | 14.23M +121.43% | -16.04M -102.21% | -- -- | -- -- | -- -- |
Net Interest Expense | -173 -- | -2.27K -- | 16.00K -- | 49.00K -- | 61.00K +35360.12% | 1.12M +49198.90% | 301.00K +1781.25% | 668.00K +1263.27% | 293.00K +380.33% | 500.00K -55.24% | 637.00K +111.63% | 515.00K -22.90% | -- -- | -- -- | -- -- |
Interest Expense | -- -- | -- -- | 16.00K -- | 49.00K -- | 61.00K -- | 1.12M -- | 301.00K +1781.25% | 668.00K +1263.27% | 293.00K +380.33% | 500.00K -55.24% | 637.00K +111.63% | 515.00K -22.90% | -- -- | -- -- | -- -- |
Interest Income | 173 -- | 2.27K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -42.55K -- | -521.48K -- | -5.38M -- | -7.33M -- | -3.67M -8521.46% | -983.00K -88.50% | -72.09M -1241.25% | -11.43M -55.88% | -14.09M -284.05% | -16.86M -1614.75% | 13.00M +118.03% | -17.23M -50.77% | -5.53M +60.76% | 283.00K +101.68% | -9.48M -- |
Income Tax Expense | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -42.55K -- | -521.48K -- | -5.38M -- | -7.33M -- | -3.67M -8521.46% | -983.00K -88.50% | -72.09M -1241.25% | -11.43M -55.88% | -14.09M -284.05% | -16.86M -1614.75% | 13.00M +118.03% | -17.23M -50.77% | -5.53M +60.76% | 283.00K +101.68% | -9.48M -- |
Net Income Attributable to Owners of the Company | -42.55K -- | -521.48K -- | -5.38M -- | -7.33M -- | -3.67M -8521.46% | -983.00K -88.50% | -72.09M -1241.25% | -11.43M -55.88% | -14.09M -284.05% | -16.86M -1614.75% | 13.00M +118.03% | -17.23M -50.77% | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -42.55K -- | -521.48K -- | -5.38M -- | -7.33M -- | -3.67M -8521.46% | -983.00K -88.50% | -72.09M -1241.25% | -11.43M -55.88% | -14.09M -284.05% | -16.86M -1614.75% | 13.00M +118.03% | -17.23M -50.77% | -- -- | -- -- | -- -- |
Other Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Basic EPS | -0.02 -- | -0.04 -- | -0.23 -- | -0.31 -- | -0.16 -700.00% | -0.07 -75.00% | -2.9 -1160.87% | -0.43 -38.71% | -0.53 -231.25% | -0.49 -600.00% | 0.48 +116.55% | -0.63 -46.51% | -0.2 +62.26% | 0.01 +102.04% | -0.34 -- |
Diluted EPS | -0.02 -- | -- -- | -0.23 -- | -0.31 -- | -0.16 -700.00% | -- -- | -2.9 -1160.87% | -0.43 -38.71% | -0.53 -231.25% | -- -- | 0.48 +116.55% | -0.63 -46.51% | -0.2 +62.26% | -- -- | -- -- |
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
